We estimate that our net proceeds from the sale of the notes in this offering will be approximately $168.5 million, after deducting underwriting discounts and commissions and estimated offering expenses that we must pay. If the underwriters option to purchase additional notes in this offering is exercised in full, we estimate that our net proceeds in this offering will be approximately $194.0 million, after deducting underwriting discounts and commissions and estimated offering expenses that we must pay.
We intend to use approximately $119.7 million of the net proceeds from this offering to fund the acquisition of DVS. We expect to use the remaining net proceeds that we will receive from this offering for research and development, commercialization of our products, working capital and other general corporate purposes.
This offering is not conditioned on the closing of the acquisition of DVS and there can be no assurance that the acquisition will be consummated. If the acquisition of DVS is not consummated, we expect to use the net proceeds that we will receive from this offering for research and development, commercialization of our products, working capital and other general corporate purposes and we may also use a portion of our net proceeds to acquire and invest in complementary products, technologies or businesses; however, we currently have no binding agreements or commitments to complete any such transaction other than our agreement to acquire DVS. Pending these uses, we may invest our net proceeds from this offering primarily in investment-grade, interest-bearing instruments. Under such circumstances, the amount and timing of our expenditures will depend on several factors, including cash flows from our operations and the anticipated growth of our business. Accordingly, our management would have broad discretion in the application of the net proceeds and investors will be relying on the judgment of our management regarding the application of the proceeds from this offering.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here. Fluidigm Corporation next reports earnings on February 10, 2014.
To receive a free e-mail notification whenever Fluidigm Corporation makes a similar move, sign up!
Other recent filings from the company include the following:
Current report, item 1.02
- March 5, 2014
Fluidigm Corporation's PRESIDENT & CEO just disposed of 6,000 shares - March 5, 2014
EVP of Fluidigm Corporation just cashed-in 3,465 options - March 4, 2014